NIH Public-Private Partnerships
The National Institutes of Health (NIH) Program on Public-Private Partnerships is designed to facilitate collaborations to improve public health though biomedical research.
- Public-Private Partnerships (PPPs) represent a way for NIH to leverage our considerable resources of many kinds to work collaboratively with both public and private partners, to achieve our mission as well as that of the partners. Partnerships may take many forms and range widely in size and scope. Partnership activities center on the shared goals and mandates of the partners, leveraging knowledge, skills, resources, and services to achieve synergy. Because PPPs represent a means for NIH to accomplish our mission, staff involvement in PPPs represent official duty activities.
- NIH Public-Private Partnerships involve the NIH in collaboration with any of a wide range of other organizations including, but not limited to, patient advocacy groups, professional societies, charitable foundations, industry members, trade organizations, and academic institutions.
- NIH Public-Private Partnerships are science-driven, aim to improve the public health, and are structured to uphold the principles of transparency, fairness, inclusiveness, scientific rigor, and compliance with Federal laws and NIH policy. Note that a relationship solely comprised of a Cooperative Research and Development Agreement, Material Transfer Agreement, Clinical Trial Agreement, or a gift is not considered a PPP.
- The PPP Program represents an important aspect of the NIH Roadmap. The PPP Program resides within the Office of the NIH Director, in the Office of Science Policy, as a reflection of its overarching potential relevance to all NIH Institutes and Centers and scientific programs. Unlike other Roadmap Programs, the Program on PPPs does not have an ‘end date’, and is expected to continue as multi-disciplinary, cross-sector science and will be of increasing interest and importance over time.
- PPPs represent another public face for the NIH. How NIH is seen, our protection of the public interest, and our protection of NIH in the view of the public, requires nuanced and scrupulous attention to details of partnership structure, policies, and goals.
This page last updated: October 6, 2010